These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 32882063)

  • 21. Health and well-being of maturing adults with classic galactosemia.
    Garrett OS; Druss JJ; Vos EN; Fu YD; Lucia S; Greenstein PE; Bauer A; Sykut-Cegielska J; Stepien KM; Arbuckle C; Grafakou O; Meyer U; Vanhoutvin N; Pané A; Bosch AM; Rubio-Gozalbo E; Berry GT; Fridovich-Keil JL
    J Inherit Metab Dis; 2024 Aug; ():. PubMed ID: 39143820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New AAV9 engineered variants with enhanced neurotropism and reduced liver off-targeting in mice and marmosets.
    Giannelli SG; Luoni M; Iannielli A; Middeldorp J; Philippens I; Bido S; Körbelin J; Broccoli V
    iScience; 2024 May; 27(5):109777. PubMed ID: 38711458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Puberty and fertility in classic galactosemia.
    Flechtner I; Viaud M; Kariyawasam D; Perrissin-Fabert M; Bidet M; Bachelot A; Touraine P; Labrune P; de Lonlay P; Polak M
    Endocr Connect; 2021 Feb; 10(2):240-247. PubMed ID: 33491660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case report of classic galactosemia with a GALT gene variant and a literature review.
    Wang YC; Lan LC; Yang X; Xiao J; Liu HX; Shan QW
    BMC Pediatr; 2024 May; 24(1):352. PubMed ID: 38778342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-body galactose oxidation as a robust functional assay to assess the efficacy of gene-based therapies in a mouse model of Galactosemia.
    Balakrishnan B; Yan X; McCue MD; Bellagamba O; Guo A; Winkler F; Thall J; Crawford L; Dimen R; Chen S; McEnaney S; Wu Y; Zimmer M; Sarkis J; Martini PGV; Finn PF; Lai K
    Mol Ther Methods Clin Dev; 2024 Mar; 32(1):101191. PubMed ID: 38352271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optical Coherence Tomography: Retinal Imaging Contributes to the Understanding of Brain Pathology in Classical Galactosemia.
    Lotz-Havla AS; Christmann T; Parhofer KG; Maier EM; Havla J
    J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Importance of Neonatal Screening for Galactosemia.
    Badiu Tișa I; Achim AC; Cozma-Petruț A
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders.
    Ghasemzad M; Hashemi M; Lavasani ZM; Hossein-Khannazer N; Bakhshandeh H; Gramignoli R; Keshavarz Alikhani H; Najimi M; Nikeghbalian S; Vosough M
    Bioengineering (Basel); 2022 Aug; 9(8):. PubMed ID: 36004917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harnessing the Power of Purple Sweet Potato Color and
    Hagen-Lillevik S; Johnson J; Siddiqi A; Persinger J; Hale G; Lai K
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galactosemia: Biochemistry, Molecular Genetics, Newborn Screening, and Treatment.
    Succoio M; Sacchettini R; Rossi A; Parenti G; Ruoppolo M
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel mRNA therapy restores GALT protein and enzyme activity in a zebrafish model of classic galactosemia.
    Delnoy B; Haskovic M; Vanoevelen J; Steinbusch LKM; Vos EN; Knoops K; Zimmermann LJI; Noga M; Lefeber DJ; Martini PGV; Coelho AI; Rubio-Gozalbo ME
    J Inherit Metab Dis; 2022 Jul; 45(4):748-758. PubMed ID: 35527402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current and Future Treatments for Classic Galactosemia.
    Delnoy B; Coelho AI; Rubio-Gozalbo ME
    J Pers Med; 2021 Jan; 11(2):. PubMed ID: 33525536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study of neonatal GALT gene replacement using AAV9 dramatically lowers galactose metabolites in blood, liver, and brain and minimizes cataracts in GALT-null rat pups.
    Rasmussen SA; Daenzer JMI; Fridovich-Keil JL
    J Inherit Metab Dis; 2021 Jan; 44(1):272-281. PubMed ID: 32882063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal GALT gene replacement offers metabolic and phenotypic correction through early adulthood in a rat model of classic galactosemia.
    Daenzer JMI; Rasmussen SA; Patel S; McKenna J; Fridovich-Keil JL
    J Inherit Metab Dis; 2022 Mar; 45(2):203-214. PubMed ID: 34964137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A galactose-1-phosphate uridylyltransferase-null rat model of classic galactosemia mimics relevant patient outcomes and reveals tissue-specific and longitudinal differences in galactose metabolism.
    Rasmussen SA; Daenzer JMI; MacWilliams JA; Head ST; Williams MB; Geurts AM; Schroeder JP; Weinshenker D; Fridovich-Keil JL
    J Inherit Metab Dis; 2020 May; 43(3):518-528. PubMed ID: 31845342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia.
    Balakrishnan B; An D; Nguyen V; DeAntonis C; Martini PGV; Lai K
    Mol Ther; 2020 Jan; 28(1):304-312. PubMed ID: 31604675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary galactosemia.
    Demirbas D; Coelho AI; Rubio-Gozalbo ME; Berry GT
    Metabolism; 2018 Jun; 83():188-196. PubMed ID: 29409891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galactosemia: when is it a newborn screening emergency?
    Berry GT
    Mol Genet Metab; 2012 May; 106(1):7-11. PubMed ID: 22483615
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.